Search
Returning search results with filters:
Remove filter for
Audience: General public
Remove filter for
Category: Drugs
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 1 - 15 of 333 items.
Jamp Digoxin tablet: Over-sized tablet
RecallHealth product recall | 2024-06-03
Unauthorized sexual enhancement products may pose serious health risks
AlertPublic advisory | 2024-05-27
Sanis Health Duloxetine 60 mg Capsule; Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-05-16
Sandoz Fesoterodine Fumarate 8 mg tablet; Out-of-specification (diester impurity)
RecallHealth product recall | 2024-05-16
REDDY-SAPROPTERIN: Color change & decrease potency
RecallHealth product recall | 2024-05-03
PMS-Duloxetine 60 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-04-17
PMS-Duloxetine 30 mg: Exceeds acceptable interim intake limit for N-nitroso-duloxetine (NDLX)
RecallHealth product recall | 2024-04-17
I-131 Diagnostic Capsule: Affected lots may have decreased thyroid uptake.
RecallHealth product recall | 2024-04-17
JAMP-Guanfacine XR 4 mg: Foreign matter
RecallHealth product recall | 2024-04-10
JAMP-Rabeprazole 20 mg: Affected lot may contain JAMP-Rabeprazole 10 mg
RecallHealth product recall | 2024-04-02
Unauthorized skin lightening and skin treatment products may pose serious health risks
AlertPublic advisory | 2024-03-27
JAMP CEPHALEXIN SUSPENSION: Suspendability out of specification
RecallHealth product recall | 2024-03-21
FOLIC ACID 1MG - Affected lots exceed or may exceed the acceptable intake limit for N-nitroso-folic acid.
RecallHealth product recall | 2024-03-12
Unauthorized health products seized from Tokyo Beauty and Healthcare store in Richmond, B.C., may pose serious health risks
AlertPublic advisory | 2024-03-08
PDP-Desonide : Tubes may leak, in the affected lot.
RecallHealth product recall | 2024-02-20